Dr Ajay Gupta, MD | |
2 Brighton Rd Ste 400, Clifton, NJ 07012-1670 | |
(862) 249-4904 | |
Not Available |
Full Name | Dr Ajay Gupta |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 45 Years |
Location | 2 Brighton Rd Ste 400, Clifton, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215974225 | NPI | - | NPPES |
3855708 | Medicaid | NJ |
Facility Name | Location | Facility Type |
---|---|---|
Hackensackumc Mountainside | Montclair, NJ | Hospital |
St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cardiology Group Wayne General Hospital | 4385690544 | 6 |
Medical Associates Of Englewood Pc | 1355512252 | 519 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
Inspire Pharmaceuticals, Inc. announced today financial results for the fourth quarter and year ended December 31, 2009, reporting a net loss of $2.6 million or ($0.03) per share for the fourth quarter and a net loss of $40.0 million or ($0.60) per share for the full year.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.
› Verified 5 days ago
Entity Name | Cardiology Group Wayne General Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063591626 PECOS PAC ID: 4385690544 Enrollment ID: O20050330000905 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
Inspire Pharmaceuticals, Inc. announced today financial results for the fourth quarter and year ended December 31, 2009, reporting a net loss of $2.6 million or ($0.03) per share for the fourth quarter and a net loss of $40.0 million or ($0.60) per share for the full year.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.
› Verified 5 days ago
Entity Name | Medical Associates Of Englewood Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
Inspire Pharmaceuticals, Inc. announced today financial results for the fourth quarter and year ended December 31, 2009, reporting a net loss of $2.6 million or ($0.03) per share for the fourth quarter and a net loss of $40.0 million or ($0.60) per share for the full year.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.
› Verified 5 days ago
Entity Name | North Jersey Vascular Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780087312 PECOS PAC ID: 3678896446 Enrollment ID: O20150427001072 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
Inspire Pharmaceuticals, Inc. announced today financial results for the fourth quarter and year ended December 31, 2009, reporting a net loss of $2.6 million or ($0.03) per share for the fourth quarter and a net loss of $40.0 million or ($0.60) per share for the full year.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ajay Gupta, MD 717 Somerset St, Franklin Lakes, NJ 07417-1036 Ph: (973) 595-5345 | Dr Ajay Gupta, MD 2 Brighton Rd Ste 400, Clifton, NJ 07012-1670 Ph: (862) 249-4904 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
Inspire Pharmaceuticals, Inc. announced today financial results for the fourth quarter and year ended December 31, 2009, reporting a net loss of $2.6 million or ($0.03) per share for the fourth quarter and a net loss of $40.0 million or ($0.60) per share for the full year.
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.
A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging.
› Verified 5 days ago
Dr. Ahmed Abdel Mekkawy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Clifton Ave, Suite 101, Clifton, NJ 07013 Phone: 973-778-5070 Fax: 973-778-2878 | |
Dr. Pearl Korenblit, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1011 Clifton Ave, First Floor, Clifton, NJ 07013 Phone: 973-928-5490 Fax: 973-928-5493 | |
Louise Ashley Albornoz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1011 Clifton Ave, Clifton, NJ 07013 Phone: 973-778-6611 Fax: 973-473-8434 | |
Dr. Fadwa Sumrein, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Brighton Rd Ste 400, Clifton, NJ 07012 Phone: 862-297-9696 Fax: 862-297-9695 | |
Joanna Crincoli, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 10 Frances St Fl 2, Clifton, NJ 07014 Phone: 973-902-4449 | |
Dr. Ravinder M Narang, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 721 Clifton Ave, Clifton, NJ 07013 Phone: 973-471-9454 | |
Kedar Sankholkar, MD, MS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1030 Clifton Ave, Clifton, NJ 07013 Phone: 973-778-3777 Fax: 973-778-3252 |